Study Examines Plasma Fatty Acids and Inflammatory Biomarkers in Heart Disease Prevention
Understanding Cardiovascular Disease
Cardiovascular disease (CVD), which includes conditions such as heart attacks and strokes, remains the foremost cause of mortality globally. To combat this pressing health crisis and improve heart disease prevention efforts, innovative strategies are essential. One notable clinical indicator of cardiovascular disease is the presence of inflammatory biomarkers detectable in the bloodstream. These biomarkers not only signify inflammation but are also linked to insulin resistance and an increased risk of cardiovascular incidents.
The Role of Fatty Acids
Fatty acids, alongside other dietary components, can influence the expression of inflammatory molecules within the body. Elevated levels of specific fatty acids in plasma are associated with various cardiovascular diseases. Conversely, polyunsaturated fatty acids exhibit cardioprotective properties by diminishing the expression of pro-inflammatory genes. Additionally, these beneficial oils can promote the production of hormones that help guard against vascular dysfunction and insulin resistance.
Research Gaps in Secondary Prevention
While some clinical studies indicate that diet impacts inflammation and insulin sensitivity, there is a lack of research focused on secondary prevention patients—those already diagnosed with cardiovascular disease who aim to hinder disease progression. A team of Brazilian researchers sought to explore the relationship between inflammatory biomarkers and plasma fatty acid levels in patients dedicated to heart disease prevention. They specifically considered the role of insulin resistance in their investigation. The clinical study involved 359 participants and the findings were published in the Nutrition Journal.
Study Participant Overview
Participants in the study were over the age of 45 and had experienced at least one indicator of established cardiovascular disease within the past decade. Blood samples were collected for clinical analysis, supplemented by questionnaires to gather general participant characteristics. Approximately half of the participants were found to be insulin-resistant, a group that comprised a higher proportion of females and was, on average, younger than their non-insulin-resistant counterparts.
Findings on Fatty Acids and Inflammatory Markers
The study revealed that inflammatory markers were elevated in the insulin-resistant group compared to others. A negative correlation was identified between inflammatory biomarkers and alpha-linolenic fatty acid levels (a type of polyunsaturated fatty acid), while a positive correlation existed between inflammatory biomarkers and stearic fatty acid levels (a saturated fat). Notably, these associations were observed solely in the non-insulin-resistant group. In the insulin-resistant participants, a negative relationship was seen between pro-inflammatory biomarkers and levels of unsaturated fatty acids (eicosapentaenoic and docosapentaenoic fatty acids). This indicates that higher saturated fat levels in the blood were associated with increased inflammation, while elevated unsaturated fat levels correlated with reduced inflammation.
Implications for Heart Disease Prevention
The findings contribute to the expanding body of literature linking cardiovascular disease risk factors and insulin resistance. Researchers noted that insulin-resistant patients exhibited increased markers of inflammation in their plasma. Furthermore, the study established that unsaturated fatty acids correlated with lower inflammatory markers among secondary heart disease prevention patients, both with and without insulin resistance. This evidence underscores the potential beneficial role of unsaturated fatty acids in inflammation reduction, thereby enhancing cardiovascular disease prevention strategies. Future studies that categorize patients based on insulin resistance could yield insights that inform more effective prevention techniques.
Reference
Bersch-Ferreira ÂC, Sampaio GR, Gehringer MO, da Silva Torres EA, Ross-Fernandes MB, da Silva JT, Torreglosa CR, Kovacs C, Alves R, Magnoni CD, Weber B. Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study. Nutrition Journal. 2018 Dec 1;17(1):26.